Articles tagged with “mantle-cell-lymphoma”

Beqalzi (Sonrotoclax) FDA Approval: BCL-2 Inhibitor for MCL

Examine the FDA accelerated approval of Beqalzi (sonrotoclax), the first BCL-2 inhibitor for relapsed mantle cell lymphoma, including efficacy and safety data.

40 min read

5/4/2026

beqalzi sonrotoclax mantle cell lymphoma mcl bcl-2 inhibitor hematologic oncology fda approval targeted therapy

Tecartus FDA Approval: ZUMA-2 Data for Mantle Cell Lymphoma

Review the FDA full approval of Tecartus for relapsed mantle cell lymphoma. This analysis covers ZUMA-2 Cohort 3 efficacy data, CAR-T safety, and clinical use.

25 min read

4/26/2026

tecartus fda approval mantle cell lymphoma car-t therapy zuma-2 trial kte-x19 clinical oncology btk inhibitors